The Bottom Line

Central centrifugal cicatricial alopecia (CCCA) is the most common cause of permanent (scarring) hair loss in Black women. It starts at the crown or central scalp and spreads outward in a circular pattern. Early diagnosis and treatment are critical — once follicles are scarred and destroyed, hair cannot regrow in those areas. However, treatment can stop the progression and preserve remaining hair, which is why seeking dermatologic care at the first signs is so important.

What Is Central Centrifugal Cicatricial Alopecia (CCCA)?

CCCA is a type of scarring (cicatricial) alopecia — a form of permanent hair loss where inflammation destroys hair follicles and replaces them with scar tissue. The name describes the pattern: it begins centrally (at the crown or vertex of the scalp), and the hair loss spreads centrifugally (outward from the center in a widening circle).

CCCA primarily affects women of African descent, with prevalence estimates ranging from 2.7% to 5.6% among Black women. It typically presents between ages 30 and 60 and progresses gradually over years. Without treatment, the area of permanent hair loss continues to expand from the crown outward, potentially affecting a large portion of the scalp.

CCCA is classified as a primary cicatricial alopecia — meaning the hair follicle itself is the target of the inflammatory process, not a secondary effect of another condition. Recent research suggests a genetic component, with variants in the PADI3 gene (which encodes a protein important for hair shaft formation) identified in some families with CCCA.

Signs and Symptoms of CCCA

Early signs (seek evaluation now):

  • Gradual thinning at the crown of the scalp — often first noticed as a widening part or visible scalp through the hair at the vertex
  • Itching, tenderness, or burning sensation on the central scalp (present in about 50% of patients)
  • Small, shiny patches at the crown where hair density is noticeably reduced
  • Breakage of hair shafts at the affected area

Progressive signs:

  • Smooth, shiny scalp skin in the affected area — follicle openings are no longer visible (this indicates scarring)
  • The thinned area gradually expands outward from the crown in a symmetric or asymmetric circular pattern
  • A "fringe" of remaining thin hairs at the expanding border of the hair loss
  • Polytrichia — remaining follicles may produce multiple thin hairs from a single opening (a compensatory response)

What Causes CCCA?

The exact cause of CCCA is not fully understood, but research points to a combination of factors:

Genetic predisposition: PADI3 gene variants have been identified in families with CCCA. This gene affects the inner root sheath of the hair follicle, potentially causing premature breakdown and inflammation. Family history of hair loss is common.

Hair care practices (contributing, not sole cause): Chemical relaxers, hot comb use, tight braiding, and high-tension styling have been associated with CCCA, though many women without these practices also develop the condition. Current thinking is that these practices may trigger or worsen CCCA in genetically predisposed individuals, but they are not the sole cause.

Inflammatory process: Biopsy shows lymphocytic inflammation surrounding and destroying the hair follicle, with progressive replacement by fibrous (scar) tissue. The inflammation targets the upper follicle (infundibulum and isthmus), destroying the stem cells necessary for hair regrowth.

Possible metabolic associations: Emerging research suggests links between CCCA and uterine fibroids, as well as type 2 diabetes, though the mechanisms are not yet clear.

Treatment Options for CCCA

Treatment goals are to stop the inflammation (halting progression), preserve remaining hair, and potentially regrow hair in areas where follicles are still viable.

Anti-inflammatory treatments (first-line):

  • Topical corticosteroids: High-potency steroid solutions or foams (clobetasol 0.05%) applied to the affected scalp daily to reduce inflammation. First-line treatment for most patients.
  • Intralesional corticosteroid injections: Triamcinolone acetonide (5-10 mg/mL) injected into the active, expanding border of hair loss every 4-6 weeks. More potent than topical steroids for controlling inflammation.
  • Oral anti-inflammatory medications: Doxycycline 100mg daily (anti-inflammatory properties at sub-antimicrobial doses), hydroxychloroquine (Plaquenil), or mycophenolate mofetil for more aggressive cases.

Hair regrowth support:

  • Topical minoxidil 5%: Applied daily to the affected area and surrounding zones to stimulate remaining viable follicles and extend the hair growth phase.
  • Platelet-rich plasma (PRP) injections: Growth factors from your own blood are injected into the scalp to stimulate follicle activity. Emerging evidence suggests benefit in CCCA.

Hair care modifications:

  • Minimize or eliminate chemical relaxers and hot comb use
  • Avoid high-tension hairstyles on the affected areas
  • Use gentle, moisturizing hair products
  • Handle hair with minimal manipulation and low heat

For advanced cases (significant permanent hair loss):

  • Hair transplant surgery may be considered once inflammation is fully controlled for 12+ months
  • Scalp micropigmentation provides cosmetic camouflage
  • Wigs, toppers, and hair pieces provide immediate coverage

When to See a Dermatologist

See a dermatologist as early as possible if you notice thinning at the crown, burning or itching on the central scalp, or a widening part line. CCCA is a race against time — the earlier treatment begins, the more hair can be preserved. A dermatologist can perform a scalp biopsy to confirm the diagnosis (CCCA has characteristic histological features) and start anti-inflammatory treatment to halt progression. Don't wait until the hair loss is extensive — every month of untreated inflammation means more permanent follicle damage.

Frequently Asked Questions

Is CCCA the same as regular female pattern hair loss?

No — they are different conditions. Female pattern hair loss (androgenetic alopecia) is non-scarring — the follicles miniaturize but are still alive and potentially responsive to treatment. CCCA is scarring — the follicles are destroyed by inflammation and replaced by scar tissue. The pattern also differs: female pattern loss typically causes diffuse thinning across the top, while CCCA starts specifically at the crown and spreads outward. A scalp biopsy distinguishes between them definitively.

Can hair grow back in areas affected by CCCA?

In areas where follicles have been completely destroyed (smooth, shiny scalp without follicle openings), hair cannot regrow — the scarring is permanent. However, in areas where follicles are still present but inflamed (the active border), treatment can preserve those follicles and sometimes restore hair growth. This is why early treatment is critical — stopping inflammation before it reaches permanent scarring saves hair.

Did my relaxer or braids cause my CCCA?

This is a complex question. Chemical relaxers and tight styling are associated with CCCA but are not considered the sole cause — many women who use these practices never develop CCCA, and some women who have never relaxed their hair still develop it. Current understanding is that CCCA has a genetic basis (PADI3 gene variants), and hair care practices may act as triggers or accelerators in genetically susceptible individuals. Modifying hair practices is still recommended as part of treatment, but guilt about past styling choices is not warranted.

How is CCCA diagnosed?

Definitive diagnosis requires a scalp biopsy — a small sample of scalp tissue from the active border of the hair loss is examined under a microscope. The biopsy shows characteristic features: lymphocytic inflammation around the upper follicle, premature desquamation (shedding) of the inner root sheath, and fibrous tissue replacing destroyed follicles. Dermoscopy (trichoscopy) can also show suggestive findings like loss of follicular openings and peripilar gray-white halos.

References

  1. Dlova NC, Fabbrocini G, Lauro C, et al. Quality of life in South African Black women with alopecia: a pilot study. Int J Dermatol. 2016;55(8):875-881.
  2. Aguh C, Dina Y, Engelman D, McMichael A. Central centrifugal cicatricial alopecia. J Am Acad Dermatol. 2021;84(2):e111-e112.
  3. Malki L, Sarig O, Romano MT, et al. Variant PADI3 in central centrifugal cicatricial alopecia. N Engl J Med. 2019;380(9):833-841.
  4. Callender VD, McMichael AJ, Cohen GF. Medical and surgical therapies for alopecias in Black women. Dermatol Ther. 2004;17(2):164-176.

Trusted Resources

CCCA caught early can be stopped. If you notice thinning at the crown, see a dermatologist as soon as possible — early treatment preserves hair.